hypoglycemic events

Related by string. * Hypoglycemic . hypoglycemics : Paul Blart hypoglycemic . hypoglycemic unawareness . hypoglycemic episodes . severe hypoglycemic . oral hypoglycemic agents . hypoglycemic coma / eventing . EVENTS . EVENT . Events . Eventing . Event : IN NO EVENT . EVENT GIVING RISE TO . Petersen Events Center . Corporate Event Announcement . event shall AME . shared Events Calendar * *

Related by context. Frequent words. (Click for all words.) 71 severe hypoglycemia 70 cerebrovascular events 69 hypoglycaemia 68 thromboembolic events 67 hyperkalemia 67 hypoglycemia 66 laboratory abnormalities 65 HbA1c levels 65 RLS symptoms 65 comorbid conditions 65 treatment emergent adverse 65 left ventricular dysfunction 65 thrombotic events 64 thromboembolism 64 antihypertensive medications 63 Hypoglycemia 63 fasting plasma glucose 63 akathisia 63 Adverse events 63 vasomotor symptoms 63 discontinuations due 63 cardiac toxicity 62 renal insufficiency 62 nonadherence 62 hypocalcemia 62 myelosuppression 62 asthma exacerbations 62 virologic failure 62 annualized relapse 62 comorbidities 62 QT prolongation 62 renal dysfunction 62 events AEs 62 intracerebral hemorrhage 62 Adverse reactions 62 exacerbations 62 myocardial infarctions 62 hypercalcemia 61 discontinuations 61 GERD symptoms 61 lactic acidosis 61 postoperative complications 61 cytogenetic response 61 vertebral fracture 61 hypokalemia 61 tumor lysis syndrome 61 mg kg dose 61 SAEs 61 myocardial infarction stroke 61 events SAEs 61 leukopenia 61 quetiapine 61 serum phosphorus 60 renal impairment 60 hepatic impairment 60 hypomagnesemia 60 orthostatic hypotension 60 virologic response 60 amenorrhea 60 coronary revascularization 60 ziprasidone 60 aripiprazole 60 rehospitalization 60 Secondary endpoints 60 proteinuria 59 hypotension 59 severe renal impairment 59 glyburide 59 left ventricular hypertrophy 59 serum concentrations 59 placebo p 59 plus methotrexate 59 peripheral edema 59 hyperglycemia 59 symptom severity 59 P = .# 59 myocardial infarction MI 59 adalimumab 59 musculoskeletal pain 59 QTc 59 hepatotoxicity 59 A1C levels 59 enalapril 59 hypertensive patients 59 placebo p = 59 limiting toxicity 58 antihypertensive drugs 58 lacosamide 58 infusion reactions 58 infarct size 58 tamsulosin 58 creatinine clearance 58 composite endpoint 58 Secondary endpoints include 58 cardiac dysfunction 58 depressive symptoms 58 lamotrigine 58 venous thrombosis 58 inflammatory lesions 58 nonsignificant 58 AEs

Back to home page